Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Huntington’s disease
Biotech
Ferrer nabs European rights for ALS asset in €500M pact
Ferrer is paying 80 million euros upfront to jointly develop neurodegenerative disease candidate pridopidine in Europe with Dutch biotech Prilenia Tx.
Darren Incorvaia
Apr 28, 2025 2:40pm
Gene therapy lowers toxic protein in mice with Huntington's
Feb 28, 2025 1:01pm
Research reveals ‘ticking DNA clock’ behind Huntington’s disease
Feb 28, 2025 9:00am
Oligonucleotide stops gene expansion driving Huntington's: study
Feb 12, 2025 2:00pm
Atalanta loads crossbow with $97M, 2 Big Pharmas in tow
Jan 28, 2025 7:00am
Study reveals expanding gene that causes Huntington's disease
Jan 17, 2025 5:00pm
